Consolidated sales for the year came to € 344 million, a figure that reflects, among other things, a 50% drop in Keyria's sales. Our other two Divisions, Savoye and Clextral, held up well in the face of the testing conditions in 2009, which saw an historic decline in industrial investment.
For more information, consult the annual report: